Abstract
Nano-drug delivery systems based on polymeric biomaterials have received considerable interest as drug delivery vehicles. In this work, radical polymerization was carried out in order to obtain nanoparticles based on a new acrylate terpolymer (PBMA-(PEG)MEMA-PDMAEMA).
Nanoparticles were developed in the form both of nanospheres and nanocapsules, an innovative kind of hollow nanoparticles with a great potential because of their low effective density and high specific surface area. The ability of the nanoparticles to load and then release a nucleic acid (DNA) to be used in cancer treatment was also investigated.
Scanning electron microscopy analysis showed a spherical shape, nanometric dimensions, and a homogeneous distribution of the nanoparticles, also confirmed by dynamic light scattering measurements. Fourier-transform infrared spectroscopy chemical imaging analysis carried out on the nanocapsules before and after removal of the core demonstrated the presence of the cavity. High-performance liquid chromatography analysis confirmed good encapsulation efficiency of DNA both for nanospheres and nanocapsules. Drug release tests showed controlled release kinetics for both the systems with a high release of DNA in the first hours. In vitro MTT assay showed that the particles do not have cytotoxic effects on the cells.
The preliminary investigation showed that the terpolymer-based nanoparticles developed in this study could be good candidates to be used as innovative and versatile gene delivery systems.
J Appl Biomater Funct Mater 2015; 13(4): e340 - e345
Article Type: ORIGINAL RESEARCH ARTICLE
DOI:10.5301/jabfm.5000251
Authors
Elena Bellotti, Niccoletta Barbani, Maria G. Cascone, Caterina CristalliniArticle History
- • Accepted on 01/05/2015
- • Available online on 14/09/2015
- • Published online on 18/12/2015
Disclosures
This article is available as full text PDF.
Introduction
Pharmaceutical carriers have been widely investigated in both laboratory and clinical settings to improve the efficiency of delivering therapeutic and diagnostic agents via different administration routes (1). Nano-drug delivery systems based on polymeric biomaterials have received considerable interest as drug delivery vehicles in recent decades (2). Polymeric nanocarriers are particles of a solid, spherical structure with at least 1 dimension <500 nm (2, 3). They are prepared from natural or synthetic polymers with a therapeutic agent encapsulated within the polymer matrix, conjugated, or absorbed onto the surface (3).
As is well known, most commonly used pharmaceuticals are not able to accumulate in the target organ or tissue in a selective and quantitative way; usually they are evenly distributed within the body. Moreover, to reach the target area, the drug has to cross many biological barriers, where it can cause adverse reactions or be partially inactivated (4-5). Preclinical and clinical studies have demonstrated that drug-loaded polymeric nanoparticles confer prolonged circulation time, protection of the drug from physiological degradation, enhanced accumulation in the target sites, reduced side effects, improved drug tolerance, and/or long term drug bioavailability (6).
In order to increase the amount of encapsulated drug, nanoparticles can be functionalized from a morphological point of view with the aim of obtaining a hollow structure. Hollow polymeric nanostructures have attracted considerable interest in recent years because of their new functionalities and unique physicochemical properties anticipated from polymeric materials at nanoscale level (7). Hollow spheres have great potential for promising applications because of their low effective density, high specific surface area, and many other advantageous properties (8). Thanks to their hollow core structure, these particular kinds of nanoparticles can encapsulate a large number of guest molecules such as drugs, enzymes, proteins, and genes (9). Although there are many strategies for preparing hollow polymeric spheres, a template is often needed (10). With the template method, hollow structures can be obtained after removing the template by dissolution, evaporation, or thermolysis. Hollow nanoparticles are often cross-linked and this offers good physical resistance, preventing their collapse during the core extraction process.
In this work, radical polymerization was carried out in order to obtain nanoparticles (NPs) based on a new acrylate terpolymer starting from butyl methacrilate, poly(ethylene glycol) methyl ether methacrylate and 2-(dimethylamino)ethyl methacrylate (PBMA-(PEG)MEMA-PDMAEMA) to be used as a platform for the delivery of a nucleic acid for cancer treatment. The idea of a new copolymer based on 3 different components is triggered by the need to combine the good properties of each element. PBMA is an acrylic polymer well known for its biocompatibility and it is often used in biomedical applications to obtain platforms for drug delivery and gene delivery (11-12-13). PDMAEMA has been largely utilized as a nonviral gene delivery system with low cytotoxicity (14-15-16). The presence of PEG chains makes the surface of the carrier more hydrophilic and minimizes the tendency to absorb proteins, thus reducing the reticuloendothelial clearance (17-18-19). NPs were developed both in the form of nanospheres (NSs) and nanocapsules (NCs) using the template method. The ability of the NPs to load and then release a nucleic acid to be used for different applications, including cancer treatment, was also investigated using a model molecule of DNA.
Materials and methods
Preparation of nanospheres and nanocapsules
Terpolymer-based NSs were obtained by radical polymerization starting from a diluted solution of BMA, (PEG)MEMA and DMAEMA (percentage molar ratio 80/10/10, respectively) in the presence of trimethylpropane trimethacrylate (TRIM) as cross-linker (20% mol/mol). The polymerization was carried out in bidistilled water in the presence of the radical initiator (Na2S2O5/(NH4)2S2O8, 10% mol/mol). The reaction was carried out for 3 h, ensuring a constant stirring at 600 rpm at 37°C. At the end of the polymerization process, the NSs were recovered, rinsed 3 times with bidistilled water in order to remove the unreacted monomers, and then freeze-dried overnight.
NCs were obtained by an innovative technique consisting in a first step during which the PMMA NPs to be used as the core were synthesized by emulsion polymerization of methyl methacrylate in the presence of SDS. Then the polymerization of the monomers around the preformed core (PMMA core/monomers weight ratio 1:5) was carried out using the procedure previously described and subsequently the core was extracted by dispersing the NCs in chloroform (Carlo Erba Reagenti, Rodan, Italy). Finally the NCs were rinsed with bidistilled water and freeze-dried overnight. All the reagents were purchased from Sigma-Aldrich (St Louis, MO, USA).
Absorption and release tests
DNA (deoxyribonucleic acid, low molecular weight from salmon sperm, Sigma-Aldrich) was dissolved in phosphate buffered solution (PBS) to obtain a concentration of 1 mg/ml. Subsequently, 10 mg of NPs were dispersed in 1 mL of DNA solution and gently stirred for 2 h. The NPs were separated from the absorption solution by ultracentrifugation (Mikro 200 Hettich Zentrifugen, Tuttlingen, Germany) at 14 000 rpm for 15 min. A solution of DNA in PBS (1 mg/ml) was centrifuged in the same conditions and subsequently analyzed by high performance liquid chromatography (HPLC; Series 200; Perkin Elmer, Waltham, MA, USA) in order to verify the possible presence of pelleted DNA. Release tests were carried out by dispersing 10 mg of DNA-loaded NPs into 1 mL of PBS at 37°C. An aliquot of the release medium was collected at predetermined intervals, and fresh PBS was reinstated. Absorption and release tests were performed in triplicate both on the NSs and NCs. The collected samples were subsequently analyzed by HPLC.
Cytotoxicity test
To evaluate the cytotoxic characteristics of the produced NPs, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenil tetrazolium bromide (MTT) assay was performed using 3T3 cells from a mouse fibroblast cell line (Cell bank Interlab Cell Line Collection; IST, Genoa, Italy). NPs were extracted in Dulbecco’s Eagle’s Modified Medium (DMEM, Sigma-Aldrich) (20 mg/ml) for 24 h at 37°C. The cells were seeded onto 48-well plates at 2 different densities: 1.2·104 cells/cm2 for the 24 h and 0.6·104 cells/cm2 for the 72 h-exposure period test. Then, 24 h after seeding, culture medium was removed from the wells and replaced with fresh culture medium (800 µL) added with 200 µL of sterile filtered NC and NS extract. For each extract 10 replicates were performed. No extracts were added to 12 wells used as negative controls (NC); 4 wells containing only cell culture medium were used as blank. The plates were incubated in a humidified atmosphere containing 5% CO2 at 37°C. After 24 h and 72 h of incubation, respectively, cell viability was measured by MTT assay as follows. A total of 100 µL of MTT solution (10% v/v with respect to the culture medium volume) were added to each well. After 4 h incubation at 37°C, the medium was completely removed and replaced with 1 mL of DMSO. After 5 min of slow agitation the absorbance was read at 570 nm using a UV spectrophotometer (V-530; Jasco, Easton, MD, USA).
Characterization of the nanoparticles
The morphology of the NPs was examined by scanning electron microscope (SEM) (JSM 5600; JEOL, Tokyo, Japan). The samples were placed on the SEM sample stage and sputter coated with gold. The mean size and polydispersity index (PDI) of the NPs dispersed in different media (ethanol, PBS, buffered solution with pH 4.00 and 9.21) were determined by dynamic light scattering (DLS) using a Zetasizer nano ZS90 (Malvern Instruments, Malvern, UK). DLS analysis were performed in triplicate on both systems.
Fourier-transform infrared (FTIR) chemical imaging analysis was carried out in order to obtain information regarding the composition of the NPs, the removal of the PMMA core and the presence of DNA after absorption tests. HPLC analysis was carried out to evaluate monomer conversion, using an Alltech Alltima C18 5u (250 mm × 4.6 mm; Fisher Scientific, Waltham, MA, USA) as a column, and acetonitrile (ACN)/water (80/20 v/v), fluxed at 1 ml/min as the internal mobile phase. The injected volume was 50 µL and the UV wavelength was 210 nm.
The final monomer conversion was evaluated using the following equation:
where C0 and Ct are respectively the initial and final monomer concentration in the reactive mass.
HPLC analysis was also performed to investigate the amount of absorbed and released DNA. Samples were analyzed using a Synergi 4u Hydro-RP C18 (80 Å, 250 mm × 3.00 mm; Phenomenex, Torrance, CA, USA) as a column and ACN/water (7/93 v/v), fluxed at 1ml/min as the internal mobile phase. The injected volume was 50 µL, and the chromatograms collected at the UV wavelength of 260 nm were used for quantitative analysis. Released kinetics were analyzed using the semi empirical equation of the power low to describe drug release from polymeric systems:
where Mt and M∞ are the absolute cumulative amounts of drug released at time t and infinite time respectively, k is a constant incorporating structural and geometric characteristics of the device and n is the release exponent, indicative of the drug release mechanism (20).
Results
Monomer conversion
The radical polymerization of monomers in diluted condition allowed the formation of NPs directly in the reaction phase. Final conversion of the 3 monomers was greater than 95% both for the NSs and NCs.
Morphological and dimensional analysis
Morphological analysis revealed a spherical shape and a rather homogeneous distribution for both the NSs and NCs, with a modest state of aggregation and a high yield (
SEM analysis of NPs. (
Quantitative information regarding the dimensions of the NPs were supplied by DLS measurements on NS and NC samples. The analysis showed an average radius between 127.5 ± 12.1 and 218.9 ± 21.2 nm for NSs and a slight increase in NC dimensions with an average radius between 163.3 ± 13.6 and 214.7 ± 19.7 nm.
Average radius and polydispersity index of nanospheres and nanocapsules
Dispersant | NSs | NCs | ||
---|---|---|---|---|
NSs = nanospheres; NCs = nanocapsules; PDI = polydispersity index. | ||||
|
|
|
|
|
pH 9.21 | 218.9 ± 21.2 | 0.61 | 198.0 ± 20.4 | 0.68 |
Ethanol | 193.0 ± 20.9 | 0.60 | 214.7 ± 19.7 | 0.63 |
PBS | 188.8 ± 17.4 | 0.53 | 190.7 ± 19.4 | 0.56 |
pH 4.00 | 127.5 ± 12.1 | 0.40 | 163.3 ± 13.6 | 0.52 |
FTIR chemical imaging analysis
FTIR chemical imaging analysis highlighted the presence of the 3 components in the NPs.
FT-IR Chemical Imaging analysis. (
FT-IR Chemical Imaging analysis on the NPs. (
Absorption test
The encapsulation efficiency was evaluated by HPLC analysis of the absorption medium at the end of the test. Both the systems showed good encapsulation efficiency, reaching a value of 67.95% for the NSs and 87.1% for the NCs. The presence of the DNA was also investigated by FTIR chemical imaging analysis. Spectra acquired from the chemical map of the samples after adsorption showed the presence of a small band that fits on the adsorption of the ester group (data not shown). The second derivative spectra of the DNA showed a diagnostic band around 1685 cm-1, related to the vibration of the carbonyl group of the DNA bases. The second derivative spectra of NSs and NCs, respectively, before absorption did not reveal the presence of the diagnostic band of the DNA. The band around 1685 cm-1 was evident once again in the second derivative spectra of the NPs after absorption, confirming the presence of the nucleic acid on the NPs.
DNA release test
The amount of released DNA from NPs was evaluated by HPLC analysis on the samples collected at predetermined intervals. The release kinetics are shown in
Drug delivery test. (
Cytotoxicity test
The cytotoxicity of the produced NPs was preliminarily tested using the MTT cytotoxicity assay. NS and NC extracts were added to 3T3 cells and the viability of the cells was evaluated after exposure periods of 24 h and 72 h, respectively. The obtained results are shown in
Cytotoxicity MTT test of NCs and NSs extracts after 24 h (❏) and 72 h (∎) of incubation with 3T3 cells. Comparison with the negative control is shown. The results are the mean ( ± SD) of 10 measurements.
Discussion and conclusions
The combination of radical polymerization of 3 distinct monomers by the precipitation method and core-shell procedure via template method allowed the production of new hollow particles with a spherical shape and nanometric dimensions.
FTIR chemical imaging analysis confirmed the successful copolymerization both for NSs and NCs. In view of a possible use of these nano-systems for gene therapy, DNA was selected as the model molecule to be loaded into NPs. Both systems showed good absorption efficiency, probably due to the presence of PDMAEMA, which provides amino groups to the terpolymer, thus improving the molecular interaction between NPs and DNA functional groups.
Moreover, the results of the absorption test demonstrated the effect of the hollow structure in maximizing the loading of nucleic acid, as shown by an evident increase in the amount of DNA encapsulated into the NCs with respect to the NSs. This behavior was also reflected on the release kinetics, which showed an amount of delivered DNA from the NCs greater than that from NSs. Both systems highlighted the typical kinetics of release from NPs (21-22-23). Analyzing the delivery profiles more in depth (
In conclusion, the results obtained in this study showed that thanks to their chemical composition, terpolymer-based NPs may be suitable systems to promote interaction with oligonucleotidic drugs, thus obtaining a carrier for the delivery of nucleic acid. The possibility of obtaining a hollow structure allows the amount of the absorbed DNA to be maximized and a more prolonged release kinetics than those from NSs. The hollow structure allows offer the advantage of allowing a higher amount of drug to be administrated using a lower amount of polymer.
The preliminary results obtained in this work encourage us to continue in the evaluation of these new polymeric nanocarriers as DNA delivery systems in view, of a possible application in gene therapy for cancer treatment once suitable modifications have been made.
Acknowledgement
Andrea Baldassare is kindly acknowledged for cytotoxicity test support in this work.
Disclosures
-
1.
Jia F Liu X Li L Mallapragada S Narasimhan B Wang Q Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. 2013 172 3 1020 1034 -
2.
Eidi H Joubert O Némos C et al. Drug delivery by polymeric nanoparticles induces autophagy in macrophages. 2012 422 1-2 495 503 -
3.
Danhier F Ansorena E Silva JM Coco R Le Breton A Préat V PLGA-based nanoparticles: an overview of biomedical applications. 2012 161 2 505 522 -
5.
Stylios GK Giannoudis PV Wan T Applications of nanotechnologies in medical practice. 2005 36 Suppl 4 S6 S13 -
6.
Cheng R Meng F Deng C Klok HA Zhong Z Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. 2013 34 14 3647 3657 -
7.
Fu GD Li GL Neoh KG Kang ET Hollow polymeric nanostructures - Synthesis, morphology and function. 2011 36 1 127 167 -
8.
Wang W Luo C Shao S Zhou S Chitosan hollow nanospheres fabricated from biodegradable poly-D,L-lactide-poly(ethylene glycol) nanoparticle templates. 2010 76 3 376 383 -
9.
Han J Song G Guo R Fabrication of polymer hollow nanospheres by a swelling evaporation strategy. 2007 45 13 2638 2645 -
10.
Han J Song G Guo R A facile solution route for polymeric hollow spheres with controllable size. 2006 18 23 3140 3144 -
11.
Chu H Liu N Wang X Jiao Z Chen Z Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer. 2009 371 1-2 190 196 -
12.
Luo YL Zhang LL Xu F Synthesis, micellization and caffeine drug release kinetics of novel PBMA-b-PNIPAAm block polymer brushes. 2012 189-190 431 442 -
13.
Xu FJ Yang WT Polymer vectors via controlled/living radical polymerization for gene delivery. 2011 36 9 1099 1131 -
14.
Mathew A Cao H Collin E Wang W Pandit A Hyperbranched PEGmethacrylate linear pDMAEMA block copolymer as an efficient non-viral gene delivery vector. 2012 434 1-2 99 105 -
15.
Kundu PP Sharma V Synthetic polymeric vectors in gene therapy. 2008 12 5-6 89 102 -
16.
Agarwal S Zhang Y Maji S Greiner A PDMAEMA based gene delivery materials. 2012 15 9 388 393 -
17.
Mathaes R Winter G Besheer A Engert J Influence of particle geometry and PEGylation on phagocytosis of particulate carriers. 2014 465 1-2 159 164 -
18.
Tao Y Han J Dou H Surface modification of paclitaxel-loaded polymeric nanoparticles: Evaluation of in vitro cellular behavior and in vivo pharmacokinetic. 2012 53 22 5078 5086 -
19.
Vroman B Ferreira I Jérôme C Jérôme R Préat V PEGylated quaternized copolymer/DNA complexes for gene delivery. 2007 344 1-2 88 95 -
20.
Siepmann J Peppas NA Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). 2012 64 163 174 -
21.
Soppimath KS Aminabhavi TM Kulkarni AR Rudzinski WE Biodegradable polymeric nanoparticles as drug delivery devices. 2001 70 1-2 1 20 -
22.
Bazylinska U Lewinska A Lamch L Wilk KA Polymeric nanocapsules and nanospheres for encapsulation and longsustained release of hydrophobic cyanine-type photosensitizer. 2014 442 42 49 -
23.
Vafayi L Gharibe S Investigation of In Vitro Drug Release from Porous Hollow Silica Nanospheres Prepared of ZnS@SiO2 Core-Shell. 2013 2013 541030
Authors
- Bellotti, Elena [PubMed] [Google Scholar] 1, * Corresponding Author ([email protected])
- Barbani, Niccoletta [PubMed] [Google Scholar] 1
- Cascone, Maria G. [PubMed] [Google Scholar] 1
- Cristallini, Caterina [PubMed] [Google Scholar] 2
Affiliations
-
Department of Civil and Industrial Engineering, University of Pisa, Pisa - Italy -
CNR, Institute for Polymers, Composites and Biomaterials (IPCB) UOS Pisa, Pisa - Italy
Article usage statistics
The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.